These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10588973)

  • 21. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
    Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW
    J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
    Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved social and language skills after secretin administration in patients with autistic spectrum disorders.
    Horvath K; Stefanatos G; Sokolski KN; Wachtel R; Nabors L; Tildon JT
    J Assoc Acad Minor Phys; 1998; 9(1):9-15. PubMed ID: 9585670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretin for autism? Not so fast.
    Health News; 2000 Feb; 6(2):6. PubMed ID: 10734825
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism spectrum disorders in early childhood: an overview for practicing physicians.
    Carr JE; LeBlanc LA
    Prim Care; 2007 Jun; 34(2):343-59; abstract viii. PubMed ID: 17666231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic treatment of autism and related disorders.
    Erickson CA; Posey DJ; Stigler KA; McDougle CJ
    Pediatr Ann; 2007 Sep; 36(9):575-85. PubMed ID: 17910205
    [No Abstract]   [Full Text] [Related]  

  • 28. Transdermal secretin for autism - a case report.
    Lamson DW; Plaza SM
    Altern Med Rev; 2001 Jun; 6(3):311-3. PubMed ID: 11410075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretin and autism: the role of cysteine.
    Connors SL; Crowell DE
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):795-6. PubMed ID: 10405495
    [No Abstract]   [Full Text] [Related]  

  • 30. Secretin in autism--a parent's perspective.
    Klaeger D; McDougle CJ
    J Autism Dev Disord; 2000 Feb; 30(1):72-3. PubMed ID: 10819124
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part I.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1124-32. PubMed ID: 7559305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What to measure in autism drug trials.
    Roseman B; Schneider E; Crimmins D; Bostwick H; Visintainer P; Jaskow PA; Accardo P
    J Autism Dev Disord; 2001 Jun; 31(3):361-2. PubMed ID: 11518490
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of secretin in the treatment of childhood autism.
    Kamińska B; Czaja M; Kozielska E; Mazur E; Korzon M
    Med Sci Monit; 2002 Jan; 8(1):RA22-6. PubMed ID: 11782669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychopharmacology in childhood disorders.
    Wiener JM
    Psychiatr Clin North Am; 1984 Dec; 7(4):831-43. PubMed ID: 6151651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary: the primacy of the scientific method.
    Tanguay PE
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1322-3. PubMed ID: 12410074
    [No Abstract]   [Full Text] [Related]  

  • 38. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.
    Martin A; Scahill L; Klin A; Volkmar FR
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):923-31. PubMed ID: 10405512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secretin treatment of autism?].
    Jørgensen M; Thomsen PH; Henriksen JH
    Ugeskr Laeger; 2002 Mar; 164(12):1676. PubMed ID: 11924292
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pervasive developmental disorders: controversies concerning the classification of autism].
    Pisula E
    Psychiatr Pol; 2000; 34(3):447-55. PubMed ID: 11055183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.